Health ❯ Healthcare

Genetic Testing

Diagnosis Rare Diseases Ancestry Personalized Medicine Ancestry Services Adverse Reactions Personal Health Information Personal Genomics Prenatal Care Proteomic Analysis

6 ARTICLES

2mo ago

Brazil’s SUS Rolls Out Whole‑Exome Sequencing to Speed Rare‑Disease Diagnosis

Samples from new state collection points will go to INC and Fiocruz laboratories in Rio as the network scales toward nationwide capacity by the end of 2026.

8 ARTICLES

4mo ago

Angelina Jolie Reveals Mastectomy Scars on Time France Cover to Urge Breast-Cancer Prevention

4 ARTICLES

6mo ago

RPS6KC1 Mutations Identified as Cause of Ultra-Rare Neurodevelopmental Disorder

5 ARTICLES

7mo ago

UCLH Becomes First NHS Trust to Offer ROCA Surveillance for BRCA-Linked Ovarian Cancer

7 ARTICLES

8mo ago

Mount Sinai Team Publishes AI ‘Penetrance’ Scores to Gauge Disease Risk From Rare Variants

10 ARTICLES

9mo ago

Global Team Releases Most Complete Human Pangenome and Maps 175,000 Structural Variants

10 ARTICLES

9mo ago

Eight Healthy Babies Born Through UK Three-Parent IVF, Study Shows

3 ARTICLES

10mo ago

Galicia Unveils €400 Million Rare Diseases Strategy to Cut Diagnosis Times by 30%

12 ARTICLES

11mo ago

23andMe Board Rejects CEO's Proposal to Take Company Private

Genetic Testing

Brazil’s SUS Rolls Out Whole‑Exome Sequencing to Speed Rare‑Disease Diagnosis

Angelina Jolie Reveals Mastectomy Scars on Time France Cover to Urge Breast-Cancer Prevention

RPS6KC1 Mutations Identified as Cause of Ultra-Rare Neurodevelopmental Disorder

UCLH Becomes First NHS Trust to Offer ROCA Surveillance for BRCA-Linked Ovarian Cancer

Mount Sinai Team Publishes AI ‘Penetrance’ Scores to Gauge Disease Risk From Rare Variants

Global Team Releases Most Complete Human Pangenome and Maps 175,000 Structural Variants

Eight Healthy Babies Born Through UK Three-Parent IVF, Study Shows

Galicia Unveils €400 Million Rare Diseases Strategy to Cut Diagnosis Times by 30%

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe

Proteomic Test Cuts Childhood Rare Disease Diagnosis to Under Three Days

Never miss stories about

Genetic Testing

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

At-home spit test for prostate cancer outperforms PSA blood test in trials

23andMe Bankruptcy Fuels Data Privacy Concerns as Deletion Requests Surge

Germany Advances Newborn Screening with Genomic Testing Initiative

NHS Introduces First-Ever Treatment for Rare Eye Cancer

23andMe Faces Financial Struggles and Data Privacy Concerns

Scientists Discover New MAL Blood Group, Solving 50-Year-Old Mystery

23andMe Settles Data Breach Lawsuit for $30 Million

23andMe Board Rejects CEO's Proposal to Take Company Private

Never miss stories about

Genetic Testing